Vaccine to prevent a dangerous tropical disease receives approval

by Estonian Research CouncilWork in Tartu University's virology lab. Author Kaspar Koolmeister. Credit: Kaspar KoolmeisterThe chikungunya virus is widespread in tropical regions, where it is sprea

Updated on: May 05,2024

Vaccine to prevent a dangerous tropical disease receives approval

by Estonian Research CouncilWork in Tartu University's virology lab. Author Kaspar Koolmeister. Credit: Kaspar KoolmeisterThe chikungunya virus is widespread in tropical regions, where it is sprea

Updated on:May 05,2024

T-cell abnormalities in severe COVID-19 cases

by Kumamoto UniversityA major difference between mild and severe cases of COVID-19 may be the extreme activation of T cells as they react to the virus. In mild cases, T cell activation is slowed

Updated on: April 12,2024

T-cell abnormalities in severe COVID-19 cases

by Kumamoto UniversityA major difference between mild and severe cases of COVID-19 may be the extreme activation of T cells as they react to the virus. In mild cases, T cell activation is slowed

Updated on:April 12,2024

Default testing for COVID-19 in K-12 schools more effective than voluntary testing

by Phil Ciciora,University of Illinois at Urbana-ChampaignGraphical Abstract. Credit:iScience(2023). DOI: 10.1016/j.isci.2023.108770A new paper co-written by a team of University of

Updated on: March 20,2024

Default testing for COVID-19 in K-12 schools more effective than voluntary testing

by Phil Ciciora,University of Illinois at Urbana-ChampaignGraphical Abstract. Credit:iScience(2023). DOI: 10.1016/j.isci.2023.108770A new paper co-written by a team of University of

Updated on:March 20,2024

Chlamydia vaccine shows promise in early trial

by Robin FosterA chlamydia vaccine has triggered immune responses in an early trial, raising hopes that one day it might help curb the spread of the sexually transmitted infection (STI).There is curre

Updated on: April 30,2024

Chlamydia vaccine shows promise in early trial

by Robin FosterA chlamydia vaccine has triggered immune responses in an early trial, raising hopes that one day it might help curb the spread of the sexually transmitted infection (STI).There is curre

Updated on:April 30,2024

A new class of antibodies against COVID-19 is being put to the test

by Garvan Institute of Medical ResearchStructural characterization of the broadly neutralizing class 1 antibody GAR05. a Cryo-EM structure of GAR05 Fab bound to trimeric spike (3.27 Å resolution)

Updated on: March 25,2024

A new class of antibodies against COVID-19 is being put to the test

by Garvan Institute of Medical ResearchStructural characterization of the broadly neutralizing class 1 antibody GAR05. a Cryo-EM structure of GAR05 Fab bound to trimeric spike (3.27 Å resolution)

Updated on:March 25,2024

SARS-CoV-2: Alert immune system in the respiratory tract protects children from severe courses of the disease

by German Cancer Research CenterSynopsis SARS-CoV-2 infection is milder in children, but the underlying mechanisms are not fully understood. This study finds increased interactions between immune

Updated on: April 22,2024

SARS-CoV-2: Alert immune system in the respiratory tract protects children from severe courses of the disease

by German Cancer Research CenterSynopsis SARS-CoV-2 infection is milder in children, but the underlying mechanisms are not fully understood. This study finds increased interactions between immune

Updated on:April 22,2024

Republic of Congo reports its first mpox virus cases, in several regions

by Louis Patrick OkambaVials of single doses of the Jynneos vaccine for monkeypox are seen from a cooler at a vaccinations site on Aug. 29, 2022, in the Brooklyn borough of New York. The Republic of C

Updated on: March 20,2024

Republic of Congo reports its first mpox virus cases, in several regions

by Louis Patrick OkambaVials of single doses of the Jynneos vaccine for monkeypox are seen from a cooler at a vaccinations site on Aug. 29, 2022, in the Brooklyn borough of New York. The Republic of C

Updated on:March 20,2024

HIV infection leaves a 'memory' in cells

by George Washington UniversityImage of HIV. Credit: C. GoldsmithContent Providers: CDC/ C. Goldsmith, P. Feorino, E. L. Palmer, W. R. McManusThough antiretroviral therapy has made HIV a manageab

Updated on: April 16,2024

HIV infection leaves a 'memory' in cells

by George Washington UniversityImage of HIV. Credit: C. GoldsmithContent Providers: CDC/ C. Goldsmith, P. Feorino, E. L. Palmer, W. R. McManusThough antiretroviral therapy has made HIV a manageab

Updated on:April 16,2024

Elucidating host-microbe interactions to address vector-borne diseases

by Serena Crawford,Yale UniversityGraphical abstract. Credit:Cell(2024). DOI: 10.1016/j.cell.2024.05.023In a new study, Yale researchers identify the targets in the human body to whi

Updated on: July 10,2024

Elucidating host-microbe interactions to address vector-borne diseases

by Serena Crawford,Yale UniversityGraphical abstract. Credit:Cell(2024). DOI: 10.1016/j.cell.2024.05.023In a new study, Yale researchers identify the targets in the human body to whi

Updated on:July 10,2024

What is eastern equine encephalitis? Two mosquito researchers explain what's behind the latest outbreaks

by Cameron Webb and Andrew van den Hurk,The ConversationBlue jays are an important host of eastern equine encephalitis virus in the United States. Credit:Mathew Schwartz/UnsplashHealth aut

Updated on: September 10,2024

What is eastern equine encephalitis? Two mosquito researchers explain what's behind the latest outbreaks

by Cameron Webb and Andrew van den Hurk,The ConversationBlue jays are an important host of eastern equine encephalitis virus in the United States. Credit:Mathew Schwartz/UnsplashHealth aut

Updated on:September 10,2024

Monkeypox Virus Could Resurge: A Potential Public Health Crisis

Updated on: August 14,2024

Monkeypox Virus Could Resurge: A Potential Public Health Crisis

Updated on:August 14,2024

COVID-19 vaccine elicits weak antibody response in people taking immunosuppressant

by Washington University School of MedicineCredit: Pixabay/CC0 Public DomainPeople who received two doses of the Pfizer COVID-19 vaccine while on TNF inhibitors—a class of immunosuppressants used

Updated on: April 12,2024

COVID-19 vaccine elicits weak antibody response in people taking immunosuppressant

by Washington University School of MedicineCredit: Pixabay/CC0 Public DomainPeople who received two doses of the Pfizer COVID-19 vaccine while on TNF inhibitors—a class of immunosuppressants used

Updated on:April 12,2024